Products for Research Use Only
RegisterLogin

Tafolecimab

CAT: 0804-HY-P99552-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99552-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia[1].
CAS Number
2225109-03-3
Product Name Alternative
IBI-306
UNSPSC
12352203
Target
PCSK9
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tafolecimab.html
Purity
95.04
Solubility
10 mM in DMSO
Smiles
[Tafolecimab]
Molecular Weight
(145.34 kDa)
References & Citations
[1]Y Cui, et al. Tafolecimab, a novel potential long-acting PCSK9 monoclonal antibody: efficacy and safety in healthy and hypercholesterolemia subjects .European Heart Journal, Volume 41, Issue Supplement_2, November 2020.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4

Alternative Products

CatalogName
T76974-01Tafolecimab
592226Tafolecimab (PCSK9)
GTR18337795-01Tafolecimab Antibody
KBI1657KRIBIOLISA™ Tafolecimab ELISA
HV275076-01Research Grade Tafolecimab
048103PCSK9 (tafolecimab) discontinued
C00784-01Tafolecimab (Anti-PCSK9)
E55B0543Tafolecimab (Reference antibody)
GTR18316324PCSK9 Reference Antibody (tafolecimab)
F1459-.1Anti-PCSK9 Antibody (Tafolecimab)

Popular Products